An expert discusses the expanded treatment options for refractory ITP, emphasizing accurate diagnosis, combination therapies targeting platelet production and destruction, and the evolving role of ...

OUR results in the treatment of idiopathic thrombocytopenic purpura with splenectomy and corticosteroids have previously been reported. In our overall, long-term, evaluation of 271 patients with ...

Aplastic anaemia is a rare and potentially life-threatening condition that can worsen during pregnancy. Its management poses unique challenges due to risks of haemorrhage, infection and transfusion ...

Platelet transfusions play a major role in the management of thrombocytopenia in hematological and oncologic patients. However, a proportion of these patients become refractory to the transfusion of ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Please provide your email address to receive an email when new articles are posted on . Rilzabrutinib demonstrated rapid, stable and durable platelet responses among patients with relapsed immune ...

Utility of prostate specific antigen doubling time (PSA-DT) at the start of androgen independent prostate cancer (AIPC) and immediately before chemotherapy in predicting efficacy of taxane ...

Thrombocytopenia, or a low platelet count, can impair blood clotting, potentially leading to severe bleeding from wounds. Underlying health conditions like autoimmune diseases and cancers, as well as ...